Cargando…
The effect of dyslipidemic drugs on mortality: A meta-analysis
Most of the previously published meta-analyses include studies exploring the effect of statins, rather than all dyslipidemic drugs, on mortality. We explored the overall effect of all dyslipidemic drugs on coronary artery disease mortality, cardio-vascular disease mortality and all-cause mortality....
Autores principales: | Jain, Shuchi, Vaishnavi, Vikas, Chakraborty, Bhaswat S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825013/ https://www.ncbi.nlm.nih.gov/pubmed/20177573 http://dx.doi.org/10.4103/0253-7613.48878 |
Ejemplares similares
-
Dyslipidemic drugs in metabolic syndrome
por: Siddiqi, Sheelu S., et al.
Publicado: (2013) -
Interim analysis: A rational approach of decision making in clinical trial
por: Kumar, Amal, et al.
Publicado: (2016) -
Effectiveness of statins vs. exercise on reducing postprandial hypertriglyceridemia in dyslipidemic population: A systematic review and network meta-analysis
por: Alvarez-Jimenez, Laura, et al.
Publicado: (2022) -
Addressing dyslipidemic risk beyond LDL-cholesterol
por: Tall, Alan R., et al.
Publicado: (2022) -
Application of critical path analysis in clinical trials
por: Kumar, Amal, et al.
Publicado: (2016)